These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8485533)

  • 1. Exposure analysis of dichotomous response measures in long-term studies.
    Peace KE; Carter WH
    J Biopharm Stat; 1993 Mar; 3(1):129-40. PubMed ID: 8485533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemfibrozil in the treatment of dyslipidemia: an 18-year mortality follow-up of the Helsinki Heart Study.
    Tenkanen L; Mänttäri M; Kovanen PT; Virkkunen H; Manninen V
    Arch Intern Med; 2006 Apr; 166(7):743-8. PubMed ID: 16606810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-only analysis of treatment-covariate interactions in clinical trials.
    Vittinghoff E; Bauer DC
    Biometrics; 2006 Sep; 62(3):769-76. PubMed ID: 16984319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial.
    Adabag AS; Mithani S; Al Aloul B; Collins D; Bertog S; Bloomfield HE;
    Am Heart J; 2009 May; 157(5):913-8. PubMed ID: 19376321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
    Greenland S; Lanes S; Jara M
    Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
    Odondi L; McNamee R
    Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical methods for active extension trials.
    Hu Z; Follmann D
    Stat Med; 2007 May; 26(12):2433-48. PubMed ID: 17066400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis patients treated with Epoetin alfa show improved anemia symptoms: A new analysis of the Canadian Erythropoietin Study Group trial.
    Keown PA; Churchill DN; Poulin-Costello M; Lei L; Gantotti S; Agodoa I; Gitlin M; Gandra SR; Mayne TJ
    Hemodial Int; 2010 Apr; 14(2):168-73. PubMed ID: 20345390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of epoetin-beta on survival of patients with lymphoproliferative malignancies: long-term follow up of a large randomized study.
    Osterborg A; Brandberg Y; Hedenus M
    Br J Haematol; 2005 Apr; 129(2):206-9. PubMed ID: 15813848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge.
    Chinchilli VM; Fisher L; Craig TJ
    J Allergy Clin Immunol; 2005 Mar; 115(3):592-7. PubMed ID: 15753909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specification test for univariate and multivariate proportional hazards models.
    Crouchley R; Pickles A
    Biometrics; 1993 Dec; 49(4):1067-76. PubMed ID: 8117901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of treatment effect adjusting for treatment changes using the intensity score method: application to a large primary prevention study for coronary events (MEGA study).
    Tanaka Y; Matsuyama Y; Ohashi Y;
    Stat Med; 2008 May; 27(10):1718-33. PubMed ID: 17922525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC
    Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 May; 9(2):307-38. PubMed ID: 10379696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analysis of small-sample multivariate data with applications in clinical trials.
    Mercante DE; Johnson WD
    J Biopharm Stat; 1993 Sep; 3(2):141-52. PubMed ID: 8220399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials methodology: randomization, intent-to-treat, and random-effects regression.
    Atkins DC
    Depress Anxiety; 2009; 26(8):697-700. PubMed ID: 19658122
    [No Abstract]   [Full Text] [Related]  

  • 19. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.